Items where authors include "Chataway, J"

Article

Webb, EJD orcid.org/0000-0001-7918-839X, Meads, D, Eskyte, I et al. (9 more authors) (2023) Decision Making About Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis: Stated Preferences and Real-World Choices. The Patient: Patient Centered Outcomes Research, 16. pp. 457-471. ISSN 1178-1653

Manzano, A orcid.org/0000-0001-6277-3752, Eskyté, I, Ford, HL et al. (8 more authors) (2020) Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders, 46. 102507. ISSN 2211-0348

Webb, E orcid.org/0000-0001-7918-839X, Meads, D orcid.org/0000-0003-1369-2483, Eskytė, I et al. (9 more authors) (2020) The impact of reproductive issues on preferences of women with relapsing multiple sclerosis for disease modifying treatments. The Patient: Patient Centered Outcomes Research, 13 (5). pp. 583-597. ISSN 1178-1653

Manzano, A orcid.org/0000-0001-6277-3752, Eskyte, I orcid.org/0000-0001-9486-0033, Ford, HL et al. (8 more authors) (2020) Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosis. Patient Education and Counseling. ISSN 0738-3991

De Angelis, F, Connick, P, Parker, RA et al. (25 more authors) (2020) Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT. Efficacy and Mechanism Evaluation, 7 (3). ISSN 2050-4365

Chataway, J, De Angelis, F, Connick, P et al. (65 more authors) (2020) Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial. The Lancet Neurology, 19 (3). pp. 214-225. ISSN 1474-4422

Eskyte, I, Manzano, A orcid.org/0000-0001-6277-3752, Pepper, G et al. (8 more authors) (2019) Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis. Multiple Sclerosis and Related Disorders, 27. pp. 370-377. ISSN 2211-0348

Connick, P, De Angelis, F, Parker, RA et al. (21 more authors) (2018) Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. BMJ Open, 8 (8). 021944. ISSN 2044-6055

Marshall, I, Thrippleton, MJ, Bastin, ME et al. (16 more authors) (2018) Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study. Journal of Neurology, 265 (8). pp. 1795-1802. ISSN 0340-5354

Webb, EJD orcid.org/0000-0001-7918-839X, Meads, D orcid.org/0000-0003-1369-2483, Eskyte, I et al. (8 more authors) (2018) A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple Sclerosis. Patient, 11 (4). pp. 391-402. ISSN 1178-1653

Pakpoor, J, Disanto, G, Altmann, DR et al. (7 more authors) (2015) No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine. Neurology: Neuroimmunology and NeuroInflammation, 2 (6). 158. ISSN 2332-7812

Vesterinen, HM, Connick, P, Irvine, CMJ et al. (8 more authors) (2015) Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis. PLoS ONE, 10 (4). e0117705. ISSN 1932-6203

Proceedings Paper

Doshi, A, De Angelis, F, Muhlert, N et al. (21 more authors) (2018) Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis. In: European Journal of Neurology. 4th Congress of the European Academy of Neurology, 16-19 Jul 2018, Lisbon, Portugal. Wiley , pp. 69-70.

De Angelis, F, Gomez, AG, Parker, R et al. (16 more authors) (2017) Examining cross-sectional relationships of optical coherence tomography, cervical cord MRI and disability in secondary progressive MS. In: Multiple Sclerosis Journal. MS Paris 2017: 7th Joint ECTRIMS - ACTRIMS Meeting, 25-28 Oct 2017, Paris, France. SAGE Publications , pp. 275-276.

Ford, H, Manzano, A orcid.org/0000-0001-6277-3752, Eskyte, I et al. (9 more authors) (2017) Understanding the treatment preferences of people with relapsing remitting multiple sclerosis. In: Multiple Sclerosis Journal. MS Paris 2017: 7th Joint ECTRIMS - ACTRIMS Meeting, 25 Oct 2017 - 28 Oct 2018, Paris, France. SAGE Publications , pp. 919-920.

Chataway, J, Chandran, S, Miller, D et al. (7 more authors) (2016) THE MS-SMART TRIAL IN SECONDARY PROGRESSIVE MS - CURRENT UPDATE. In: Journal of Neurology, Neurosurgery and Psychiatry. ABN Annual Meeting, 17-19 May 2016, Brighton, UK. BMJ Publishing Group , e1-e1.

Chataway, J, Chandran, S, Miller, D et al. (6 more authors) (2016) RECRUITMENT IN MULTIPLE SCLEROSIS TRIALS: THE MS-SMART EXPERIENCE. In: Journal of Neurology, Neurosurgery and Psychiatry. ABN Annual Meeting, 17-19 May 2016, Brighton, UK. BMJ Publishing Group , e1-e1.

Book

Manzano, A orcid.org/0000-0001-6277-3752, Ford, HL, Potrata, B, Eskyte, I, Meads, D, Webb, E orcid.org/0000-0001-7918-839X, Pepper, G, Schmierer, K, Chataway, J, Pavitt, S and Bekker, H orcid.org/0000-0003-1978-5795 (2019) Treatment Decision Making and Relapsing Remitting Multiple Sclerosis: The CRIMSON Project Decision Aid Booklet. University of Leeds .